| Characteristic |
With CSP (Prevalence) |
Male (Prevalence) |
Female (Prevalence) |
Without CSP (%) |
Male (%) |
Female (%) |
| Sample (N=479, 310 males, 169 females) |
110 (22.96) |
75(24.19) |
35 (20.71) |
369 (77.04) |
235 (75.81) |
134 (79.39) |
| Large CSP (% out of total CSP) |
58/110 (52.73) |
41/75 (54.66) |
17/35 (48.57) |
- |
- |
- |
| Age total 57.44 ± 15.37 |
54.13 ± 14.55 |
53.27 ±10.15 |
55.61 ± 9.14 |
59.67 ± 14.88 |
58.57 ± 8.56 |
61.26 ± 10.23 |
| Large CSP |
|
|
|
|
|
|
| Age |
52.25 ± 13.24 |
51.04 ± 11.17 |
54.21 ± 12.22 |
|
|
|
| Asymptomatic (normal by standard) |
16/60 (26.67) |
10/42 (23.81) |
6/18 (33.33) |
337/369 (91.32) |
211/235 (89.79) |
126/134 (94.03) |
| Symptomatic cava ≥ 6.0 mm |
|
|
|
|
|
|
| Schizophrenia* |
18/44 (40.91) |
14/32 (43.75) |
4/12 (33.33) |
5/32 (15.62) |
4/24 (16.67) |
1/8 (12.5) |
| Alcoholism** |
16/44 (36.36) |
11/32 (34.38) |
5/12 (41.67) |
12/32 (37.50) |
9/24 (30.75) |
3/8 (37.5) |
| Brains with past head trauma** |
10/44 (22.73) |
7/32 (21.87) |
3/12 (25) |
15/32 (46.88) |
11/24 (45.83) |
4/8 (50) |
| Symptomatic cava |
44/60 (73.33) |
32/42 (76.19) |
12/18 (66.67) |
32/369 (8.67) |
24/235 (10.21) |
8/134 (5.97) |
| TOTAL |
60/110 (54.54) |
42/75 (56) |
18/32 (51.43) |
369 |
235 |
134 |
Relative risk=15.78, **RR=23.24, ***RR=9.39, OR 4.52-19.38. |
